Limited time75% off all plans
Get the app

Pediatric HIV

On this page

Transmission & PPTCT - The Unwanted Inheritance

  • Vertical Transmission: Accounts for >90% of pediatric cases.
    • In-utero (placental): ~25-35% of transmission.
    • Intra-partum (delivery): ~60-70%; highest risk.
    • Post-partum (breastfeeding): ~10-15% risk.
  • Major Risk Factor: High maternal plasma viral load (>1000 copies/mL).

⭐ The majority of mother-to-child HIV transmission occurs during the intra-partum period (delivery).

Diagnosis - Spotting the Stowaway

  • Antibody Tests (ELISA/Western Blot): Unreliable for diagnosis in infants < 18 months. Transplacental maternal IgG antibodies persist, causing false-positive results. An antibody test at 18 months helps confirm final HIV-negative status.

  • Virological Assays (Gold Standard): HIV DNA PCR is the definitive method. It detects proviral DNA within the infant's own cells, enabling Early Infant Diagnosis (EID).

⭐ A single positive virological test is insufficient for diagnosis. A confirmatory repeat test on a new blood sample is mandatory to finalize the diagnosis of HIV infection.

  • Diagnostic Algorithm:

Clinical Features & Staging - The Symptom Medley

  • WHO Clinical Staging: A progressive spectrum from mild to severe.
    • Stage 1: Asymptomatic or Persistent Generalized Lymphadenopathy (PGL).
    • Stage 2: Unexplained hepatosplenomegaly, papular pruritic eruptions, recurrent URIs.

      ⭐ Painless, bilateral parotid gland enlargement is a highly characteristic early sign.

    • Stage 3: Moderate malnutrition, oral hairy leukoplakia, Lymphoid Interstitial Pneumonitis (LIP), pulmonary TB.
    • Stage 4 (AIDS-defining): Severe wasting/stunting, Pneumocystis jirovecii pneumonia (PJP), recurrent severe bacterial infections (≄2/year), CMV retinitis.

Pediatric HIV: Bilateral Parotid Swelling

Management & ART - Fighting Back Early

  • Goals: Suppress viral replication (↓VL), restore immune function (↑CD4), reduce morbidity & mortality.

  • Initiation (NACO): Treat All! Initiate ART for all children with HIV, regardless of WHO stage or CD4 count.

  • First-Line ART Regimens:

    • < 3 years: Abacavir (ABC) + Lamivudine (3TC) + Lopinavir/r (LPV/r).
    • > 3 years: ABC + 3TC + Dolutegravir (DTG).
    • > 10 years (>35kg): Tenofovir (TDF) + 3TC + DTG.
  • Second-Line ART: Guided by resistance testing after first-line failure. Involves switching to a new drug class.

  • PJP Prophylaxis (Co-trimoxazole):

    • Start for ALL HIV-exposed infants at 4-6 weeks of age.
    • Continue until HIV infection is reliably excluded.

⭐ All infants born to HIV+ mothers receive ART prophylaxis at birth (e.g., Nevirapine) and MUST start Co-trimoxazole prophylaxis at 6 weeks of age.

High‑Yield Points - ⚔ Biggest Takeaways

  • Vertical transmission is the most common route of infection in children.
  • HIV DNA PCR is the diagnostic test of choice for infants <18 months.
  • CD4 counts are physiologically higher in children; use age-specific percentages for staging.
  • PJP prophylaxis with Cotrimoxazole is critical, started at 4-6 weeks of age.
  • Lifelong ART is recommended for all HIV-infected children, irrespective of clinical or immunological stage.
  • Live vaccines (MMR, Varicella) can be given if the child has a CD4 count >15%.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE